Back to Research
white paperscience
ECAP: Endocannabinoid-Associated Pathways
Research into the neurocognitive architecture of endocannabinoid-associated pathways and their effects on cognition and wellness.
March 2025
ECAP (Endocannabinoid-Associated Pathways) is a research project examining the neurocognitive architecture of the body's endocannabinoid system - how it affects cognition, wellness, and therapeutic outcomes.
Research Focus
The endocannabinoid system is one of the most important and least understood regulatory systems in the human body. This research explores:
- The neurocognitive architecture of endocannabinoid-associated pathways
- How the endocannabinoid system interfaces with cognitive function
- Therapeutic implications for wellness and health outcomes
- The gap between popular understanding and scientific evidence
Approach
This work combines pharmacological knowledge (Dr. Bullock's background as a licensed pharmacist) with cognitive science research to bridge the gap between clinical evidence and practical understanding.
Key Outputs
- Full white paper on ECAP neurocognitive architecture
- Accessible guide: "Your Body's Secret Super-Network"
- Research brief on cannabis effects in healthy populations